Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01436487 · ClinicalTrials.gov registry record · Phase 2
Study to Examine the Effects of MultiStem in Ischemic Stroke
A Phase 2 study, sponsored by Healios K.K..
- Completed
- Registry status
- Phase 2
- Development phase
- 134
- Enrollment target
NCT01436487 is a Phase 2 study that has completed, run by Healios K.K.. The registered enrollment target is 134 participants.
The verdict
NCT01436487, a Phase 2 study, has completed, sponsored by Healios K.K..
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 134 participants
- Enrollment target
Study Summary
A study to examine the safety and potential effectiveness of the adult stem cell investigational product, MultiStem, in adults who have suffered an ischemic stroke. The hypothesis is that MultiStem will be safe and provide benefit following an ischemic stroke.
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL MultiStem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2011-10 |
| Est. Completion | 2015-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01436487
The ClinicalTrials.gov registry entry for NCT01436487 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Healios K.K., which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01436487 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01436487 about?
NCT01436487 is a clinical study titled "Study to Examine the Effects of MultiStem in Ischemic Stroke". A study to examine the safety and potential effectiveness of the adult stem cell investigational product, MultiStem, in adults who have suffered an ischemic stroke. The hypothesis is that MultiStem will be safe and provide benefit following an ischemic stroke.
What is the current status of trial NCT01436487?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 134 participants. The study started on 2011-10. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01436487?
The interventions under investigation include: Placebo (BIOLOGICAL), MultiStem (BIOLOGICAL).
Who is sponsoring clinical trial NCT01436487?
This trial is sponsored by Healios K.K., which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.